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Small Molecule Modulation
of the Human Chromatid Decatenation Checkpoint
the activation and fidelity of these checkpoints is impor-
tant for understanding genomic stability and for the de-
velopment of improved strategies for the treatment of
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1Departments of Molecular and Cellular Biology diseases involving aberrant cell proliferation or alter-
ations of chromosomal DNA.2Departments of Chemistry and Chemical Biology
3 ICB-Initiative for Chemical Genetics An important component to the maintenance of geno-
mic stability is the proper separation of newly replicated4 Howard Hughes Medical Institute
Harvard University sister chromatids prior to chromosome segregation dur-
ing mitosis (M phase) [3–5]. Sister chromatids are com-12 Oxford Street
Cambridge, Massachusetts 02138 posed of DNA complexed with histones and a variety
of associated proteins that collectively constitute chro-5Department of Biological Chemistry and Molecular
Pharmacology matin. During DNA replication (S phase), sister chroma-
tids become highly concatenated (intertwined) alongHarvard Medical School and
Department of Cancer Biology their lengths because the replicating strands of DNA
exist in a coil (Figure 1A) [2, 6]. In order to form individual-The Dana Farber Cancer Institute
Boston, Massachusetts 02115 ized chromosomes in preparation for chromosome seg-
regation, sister chromatids are decatenated starting in6 Department of Biochemistry and Molecular
Biology the G2 phase of the cell cycle by the activity of evolution-
arily conserved proteins known as type II topoisomer-University of British Columbia
Vancouver, British Columbia V6T 1Z3 ases (TopoII) [6–9]. This process involves the formation
of a double-strand DNA break and covalent linkage ofCanada
the 5 phosphoryl group of each DNA strand to form a
protein-tyrosyl intermediate (Figure 1A). These transfor-
mations are followed by the passing of a second intactSummary
DNA strand through the break and the rejoining of the
double-stranded break (Figure 1A).After chromosome replication, the intertwined sister
In addition to their importance as basic research tools,chromatids are disentangled by topoisomerases. The
small molecules targeting the TopoII family are impor-integrity of this process is monitored by the chromatid
tant clinically as cancer chemotherapeutics and as anti-decatenation checkpoint. Here, we describe small
microbial agents [7, 9, 10]. One class of small moleculesmolecule modulators of the human chromatid deca-
targeting TopoII, which includes doxorubicin and ellip-tenation checkpoint identified using a cell-based,
ticine (Figure 1B), interfere with its DNA rejoining activitychemical genetic modifier screen. Similar to 1,2,7-tri-
by stabilizing a covalent TopoII-DNA complex. Treatmentmethylyxanthine (caffeine), these small molecules sup-
of mammalian cells with this class of small moleculespress the G(2)-phase arrest caused by ICRF-193, a
results in widespread DNA damage due to double-small molecule inhibitor of the enzymatic activity of
stranded breaks and the activation of the DNA damage-topoisomerase II. Analysis of specific suppressors,
induced G1 and/or G2 checkpoints [1, 2, 11–14]. Anotherhere named suptopins for suppressor of Topoisomer-
class of small molecules targeting TopoII, which includesase II inhibition, revealed distinct effects on cell cycle
ICRF-193 (meso-2,3-bis[2,6-dioxopiperazin-4-yl]bu-progression, microtubule stability, nucleocytoplasmic
tane) (Figure 1C), inhibits its enzymatic activity, therebytransport of cyclin B1, and no effect on the chromatin
trapping TopoII in a “closed-clamp” rather than in adeacetylation checkpoint induced by trichostatin A.
TopoII-DNA covalent complex [10, 15]. This conforma-The suptopins provide new molecular tools for dis-
tional state of TopoII occurs after strand passage andsecting the role of topoisomerases in maintaining ge-
DNA religation but before the hydrolysis of adenosinenomic stability and determining whether inhibiting the
triphosphate, which prevents the additional decatena-chromatid decatenation checkpoint sensitizes tumor
tion necessary for entry into mitosis. As a result, cellscells to chemotherapeutics.
arrest in the G2 phase due to the activation of what has
been referred to as the chromatid decatenation check-
Introduction point [16–21].
Unlike the DNA damage-induced or mitotic spindle
The maintenance of genomic stability in eukaryotic cells assembly checkpoints, there appears to be no counter-
involves an evolutionarily conserved set of signaling net- part to the chromatid decatenation checkpoint in the
works termed cell cycle checkpoints [1, 2]. These net- budding or fission yeast [2]. Consequently, understand-
works function to detect incompletely replicated, dam- ing the molecular mechanisms of this checkpoint has
aged, or abnormally structured deoxyribonucleic acid lagged behind that of other checkpoints. From the origi-
(DNA) and to arrest cell cycle progression to allow for nal discovery by Downes et al. [16], the signal transduc-
repair or cell death. Elucidating the molecular basis for tion leading to cell cycle arrest in response to ICRF-193
was found to be sensitive to the small molecule 1,2,7-
trimethylyxanthine (caffeine) and to the structural analog*Correspondence: stuart_schreiber@harvard.edu
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Figure 1. Overview of the Chromatid Decatenation Checkpoint and the Topoisomerase II-Dependent Regulation of Entry into Mitosis
(A) Schematic of the role of TopoII in catalyzing the decatenation of sister chromatids and structures of small molecules known to suppress
the DNA damage-independent (caffeine [16, 22, 24], leptomycin [18]) and DNA damage-dependent (okadaic acid [23]) G2 checkpoint activated
upon treatment with TopoII inhibitors.
(B) Chemical structures of two inhibitors of TopoII that stabilize covalent TopoII-DNA complexes.
(C) Chemical structure of ICRF-193 (meso-2,3-bis[2,6-dioxopiperazin-4-yl]butane), an inhibitor of the enzymatic activity of TopoII, which traps
it in a closed-clamp conformation.
(D) Components of the network regulating the ICRF-193-induced chromatid decatenation checkpoint (modified from [18] and [20]).
2-aminopurine [22]. Addition of caffeine to ICRF-193- of cyclin B1 [20]. Consistent with this finding, leptomycin
B (an inhibitor of nuclear export [27]) or overexpressiontreated cells produces aberrant mitotic figures with ab-
normally elongated and intertwined chromatids con- of cyclin B1 [18] bypassed the ICRF-193-induced arrest,
presumably through affecting the equilibrium of activetaining a core scaffold of chromosomal proteins [18, 22].
Evidence for the importance of phosphorylation in the nuclear and cytoplasmic complexes of cyclin B1/Cdk1
involved in regulating mitotic entry [28].chromatid decatenation checkpoint was demonstrated
by the ability of the protein phosphatase 1 and 2A inhibi- Besides detecting insufficient decatenation of sister
chromatids, a DNA damage-independent G2 checkpointtors (e.g., okadaic acid, Figure 1A) to overcome the G2
arrest [23]. More recently, the signal generated by ICRF- delays the entry of cells into mitosis in response to
aberrant acetylation of chromatin [30, 31]. This chroma-193 treatment was shown to be independent of the
phosphatidylinositol 3 kinase family member ATM tin deacetylation checkpoint is induced upon treatment
of cells with histone deacetylase (HDAC) inhibitors, such(ataxia telangiectasia mutated) and p53 [18, 21] but de-
pendent upon ATR (ATM and radiation arrest deficient as trichostatin A [31–33]. This checkpoint appears to be
absent in a number of tumor cell lines, which may be3-related) signaling, which is known to be inhibited by
caffeine (Figure 1D) [24–26]. In turn, ATR activation, relevant to the differential sensitivity of different tumor
cell lines [31] to treatment with HDAC inhibitors. In thethrough a mechanism involving the tumor suppressor
BRCA1, was proposed to inhibit polo-like kinase 1 (Plk1) case of trichostatin A, the cell cycle arrest can be sup-
pressed by a set of 23 recently described small mole-activity, resulting in altered nucleocytoplasmic transport
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cules [33]. The targets of these small molecules may the other library members screened in at least one of
the three assays. After removing descriptors with noinclude components of the signaling network required
for cell cycle arrest. Complexes containing TopoII pos- variance, a total of 155 graph-theoretic, information-
theoretic, or physiochemical descriptors were consid-sess HDAC and chromatin remodeling activities [34, 35].
However, the relationship between the decatenation ered for each small molecule. Since many of these mo-
lecular descriptors are redundant, principal componentcheckpoint and the chromatin deacetylation checkpoint
remains poorly understood. analysis (PCA) was used to reduce the dimensionality
of the descriptor space to a set of linearly independent,To discover small molecule modulators of the human
chromatid decatenation checkpoint and to clarify its composite descriptors that best represent the variance
of the data [43, 44]. The resulting representation pro-relationship to the chromatin deacetylation checkpoint,
we took an approach similar to that used to identify vides a global, linear model of the information describing
the structures of the small molecules. The componentssmall molecule modulators of the DNA-damage-induced
G2 checkpoint [36–39] and trichostatin A-induced cell of the first three eigenvectors were used to position
each of the small molecules in a reduced 3-D chemicalcycle arrest [33]. This approach relies on the logic of
classical genetics in which the identification of suppres- space. Accordingly, this model accounted for a total of
37% of the variance in the molecular descriptors, withsor and enhancers of a particular phenotype has been
a fruitful means to identify systematically components the full dimensionality spanning 147 dimensions instead
of the original 155 (see Supplemental Figure S1 onlineof complex biochemical networks.
at http://www.chembiol.com/cgi/content/full/10/12/
1267/DC1/). Using the coding determined by the cluster-Results
ing of the biological assay data, one of four colors was
assigned to each of the different classes of biologicallyA chemical genetic modifier screen was performed us-
active small molecules, yielding a mapping of biologicaling a cytoblot assay (described in full in [40]) to identify
measurement space onto chemical space (Figure 3C).small molecules that modify the cellular effects of ICRF-
Figure 3D depicts a composite distribution of the 132193 (Figure 1C), resulting in suppression (bypass) of the
biologically active small molecules (left) and inactivedecatenation checkpoint and entry into mitosis. As a
small molecules that segments the chemical spacemodel mammalian cell type, A549 lung carcinoma cells
studied into “coding” (those molecules that cause awere used because they are adherent and possess an
phenotype) and “noncoding” (those molecules that dointact chromatid decatenation checkpoint that can be
not cause a phenotype or have not been tested) regions.activated by ICRF-193. After screening 9600 small mole-
cules (20 M) and two rounds of retesting, a total of
20 small molecules reproducibly increased the number Diversity of ICRF-193 Suppressors
of A549 cells capable of entering mitosis in the presence One approach to proceeding with the characterization
of ICRF-193 (Figure 2). of the ICRF-193 suppressors was to choose small mole-
To investigate the relationship between different cell cules based upon their potency. However, our previous
cycle checkpoints, the data from this chromatid deca- experience with identifying small molecules functioning
tenation checkpoint screen were compared with those through different mechanisms highlighted the short-
from the chromatin deacetylation checkpoint (trichosta- comings of simply selecting the most potent hits for
tin [TSA]-modifier) [33] and mitotic screens [41, 42]. This further characterization. For example, the twelve most
comparison involved the same 9600 small molecules potent anti-mitotics selected from the screen of the
used at the same concentration and in the same cells. same library as studied here all shared the same intracel-
In total, 132 compounds were active in at least one of lular target (tubulin), with monastrol, an inhibitor of Eg5,
the three assays (Figure 3A). Hierarchical clustering of being identified as a weak anti-mitotic in the primary
the distance matrix, computed from using the Tanimoto screen [41, 42]. An alternative approach is to choose
coefficient, classified the small molecules into four sets small molecules based upon different structural classes.
(Figure 3B). Anti-mitotics (causing an arrest in the mitotic Visual inspection of the 3-D chemical structures that are
state) comprise the largest set, the majority of which shown in Figure 2D reveals similarities between certain
cause microtubule destabilization, resulting in activation molecules; however, such an ad hoc approach is unable
of the spindle assembly checkpoint [41]. Two small mol- to compare quantitatively a large number of structures
ecules scored in the anti-mitotic and TSA-modifier and properties. To make selections in an unbiased and
screen [33]. No small molecules, however, scored in the more quantitative fashion, the assumption was made of
ICRF-193 assay and any other assay, or in all three an inverse relationship between the distance spanning
assays. two small molecules in a 3-D PCA model of the associ-
ated chemical space and the likelihood that the small
molecules target the same component of the underlyingPositions of ICRF-193 Suppressors on a Global
Map of Chemical Space signaling network. To determine quantitatively these re-
lationships, the molecular descriptors used in the globalTo determine global similarities/differences between the
regions of chemical space selected by the ICRF-193- model of the chemical space were compiled for the local
region of chemical space containing only the suppres-modifier, TSA-modifier, and anti-mitotic screens, the
132 biologically active small molecules were coded ac- sors of ICRF-193, and PCA was performed again. After
removing descriptors with zero variance, a total of 159cording to the clustering of the screening data. A set of
molecular descriptors was then computed for these and descriptors were considered. The first three dimensions
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Figure 2. Summary of a Chemical Genetic Modifer Screen of 9600 Small Molecules for Suppressors of ICRF-193
(A) Film exposure of cytoblot assay using the TG-3 mAb. A549 cells have an intact chromatid decatenation checkpoint that can be activated
by addition of ICRF-193 (7 M) and suppressed by two of the modifiers of ICRF-193 (1 pin 25-50 M, two pins 50 M). Nocodazole (332
nM) was added at the time of addition of suppressors to trap cells that have bypassed the chromatid decatenation checkpoint and entered
mitosis.
(B) Summary of screening results after two rounds of retesting using the TG-3 mAb cytoblot assay.
(C) Example of retest data for the 20 suppressors (two pin transfers; 25–50 M) showing the average (n  2) value of TG-3 signal relative
to the DMSO (n  10) control alone (labels correspond to structures shown in (D). Error bars correspond to one standard deviation of the
mean. Increased TG-3 signal corresponds to increased bypass of the decatenation checkpoint and accumulation in mitosis. Small molecules
that had a TG-3 mAb signal equal to (or greater than) the mean plus 1.5 standard deviations of DMSO treated control cells (in at least two
independent retests) were considered to be biologically active.
(D) Chemical structures of 20 small molecule suppressors of the ICRF-193-induced chromatid decatenation checkpoint. Small molecules
characterized further in this work are: 22 P11 (suptopin-1), 28 E19 (suptopin-2), and 33 N15 (suptopin-3).
in the reduced space accounted for a total of 55% of within the graph (green arrows) (Figure 4C) from which
the small molecules named suptopin-1, suptopin-2, andthe variance in the molecular descriptors, with the full
dimensionality spanning 21 dimensions instead of the suptopin-3 (for suppressor of topoisomerase inhibition)
were selected for further cell biological analysis (Fig-original 159 (Figure 4A). The set of ICRF-193 suppres-
sors is therefore less diverse than the whole library. ure 4D).
The coordinates of the compounds in the 21-D reduced
space were then used to construct a Euclidean distance Mitotic Spreads and Immunofluorescence
Although the screen we used had the capacity to identifymatrix, which was then subject to hierarchical cluster-
ing. From this analysis, three distinct clusters emerged small molecules directly targeting components of the
Chemical Genetics of Chromatid Decatenation
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Figure 3. Multidimensional Analysis of Three Cell-Based Screens of 9600 Small Molecules: Suppressors of ICRF-193, Suppressors of Tricho-
statin A, and Anti-mitotics.
(A) Summary of combined screening results.
(B) Hierarchical clustering of biological assay data depicting four clusters of small molecules corresponding to 20 suppressors of ICRF-193,
21 suppressors of ITSA1, 89 anti-mitotics, and 2 small molecules that scored in both the anti-mitotic and trichostatin suppressor screen.
(C) Position of the four clusters of small molecules in a 3-D molecular descriptor space formed from the first three principal components
(PCA) axes (1–3), which account for 37% of the total variation in the data. Axes shown run parallel to indicated PCA axes.
(D) Composite representations of chemical space depicting biologically active (coding) and inactive (noncoding) small molecules colored
based upon the clustering of assay data from cell-based assays for suppressors of ICRF-193 (red), suppressors of trichostatin (green), and
anti-mitotics (blue). Axes shown run parallel to indicated PCA axes (see Supplemental Figure S1 for an enlarged representation of the entire
chemical space of the 15,120 small molecules).
chromatid decatenation checkpoint (e.g., as caffeine might affect directly the phosphorylation status of pro-
teins that are recognized by the TG-3 mAb. Furthermore,does with ATR), the assay itself is an indirect measure
based upon the level of the phosphorylated epitope although no compounds scored in both ICRF-193-mod-
ifier and anti-mitotic screens (Figure 3B), additional phe-recognized by the TG-3 mAb [36]. Consequently, small
molecules that scored positive in the primary assay notypic effects at higher concentrations/durations of
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Figure 4. Principal Component Analysis of a 159-D Chemical Space Derived from the Molecular Descriptors of the ICRF-193 Suppressors
(A) Variance accounted for by each eigenvalue/eigenvector and plot of cumulated variance of the reduced 21-D space.
(B) Positions of the 20 ICRF-193 suppressors according to their coordinates from the first three PCA axes (1–3). Shading (blue to red)
indicates increased weighting on 1.
(C) Hierarchical clustering of the 20 ICRF-193 suppressors showing three main clusters (green arrows) of small molecules from which suptopin-1
to -3 were chosen for further analysis.
(D) Chemical structures of suptopin-1 to -3.
treatment or unexpected effects due to synergy with number of mitotic cells was decreased compared to the
DMSO control, as expected due to the dominance ofnocodazole might occur. To explore these possibilities,
mitotic spreads were performed on cells treated with ICRF-193 pretreatment over the anti-mitotic effect of
nocodazole. Upon the addition of caffeine, suptopin-2,suptopin-1, -2, or -3 (Figures 5A and 5B). In the absence
of ICRF-193, neither caffeine nor suptopin-3 had an ef- or suptopin-3, there was a strong increase in the number
of mitotic cells compared to DMSO, whereas suptopin-1fect on the percentage of mitotic cells compared to
the control solvent dimethylsulphoxide (DMSO) alone. had a weaker effect and caused some visible cell death.
In contrast to the hypercondensed chromosomes seenIn contrast, both suptopin-1 and suptopin-2 caused an
increase in the number of mitotic cells, with the resulting upon treatment of cells with only suptopin-2, cells
treated with suptopin-2 in the presence of ICRF-193chromosomes hypercondensed compared to normal
mitotic chromosomes. The fact that suptopin-1 and sup- appeared to have elongated chromosomes with paired
sister chromatids. This chromosomal morphology wastopin-2 caused a mitotic defect in the absence of ICRF-
193 but did not score as anti-mitotics in the original similar to the effect of caffeine and suptopin-3.
To test for additional phenotypic effects, A549 cellsassay is likely due to differences in concentration and
duration of treatment. In the presence of ICRF-193, the treated with suptopin-1 to -3 were fixed and incubated
Chemical Genetics of Chromatid Decatenation
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with fluorescently labeled phalloidin to observe actin
microfilaments, a fluorescently labeled anti--tubulin
antibody to observe the microtubule cytoskeleton, and
Hoechst 33342 to observe chromatin (data not shown).
None of the compounds appeared to affect the actin
cytoskeleton or cause significant alterations in chroma-
tin. However, in interphase cells, suptopin-1 destabi-
lized microtubules, while suptopin-2 and suptopin-3 had
no observable effect. In mitotic cells, suptopin-1 caused
hypercondensed chromosomes with clearly aberrant
spindles, reminiscent of the effects of nocodazole, sup-
topin-2 caused a disorganized mitotic spindle with an
apparent absence of cells in telophase, and suptopin-3
had no observable effect.
Analysis of Cell Cycle and Nuclear
Size Using Flow Cytometry
Since suptopin-2 and suptopin-3 had no effect on in-
terphase microtubules, they were chosen for further
characterization by dual-parameter flow cytometry, us-
ing the TG-3 mAb to measure the number of A549 cells
in mitosis, and propidium iodide staining to quantify
DNA content (Figures 6A and 6B) [45]. Similar to the
mitotic spread analysis, in the absence of ICRF-193,
suptopin-2 caused approximately a 6-fold increase in
the number of mitotic cells (area III), whereas caffeine
and suptopin-3 had no effect. In the presence of ICRF-
193 and nocodazole, the number of DMSO-treated mi-
totic cells (area III) decreased by over half. The number
of DMSO-treated cells in G2 phase, which were negative
for TG-3 mAb staining but had a 4 N amount of DNA,
increased by over 3-fold. In the presence of ICRF-193
all three compounds—caffeine (15-fold), suptopin-2 (10-
fold) and suptopin-3 (6-fold)—caused an increase in the
number of TG-3 mAb positive cells with a 4 N amount
of DNA, indicating a bypass of the checkpoint arrest.
Besides arresting A549 cells prior to mitosis, an in-
crease in the average diameter of interphase nuclei oc-
curs upon treatment with ICRF-193, a phenotype visible
by fluorescent microscopy (data not shown). CorrelatedFigure 5. Effect of the Suptopins on the Mitotic Index and Chromo-
somal Morphology of A549 Cells with this increase in nuclear size was an increase that
was observed during flow cytometry (Figure 6C) in the(A) Mitotic index obtained from counting the frequency of mitotic
cells (n  total number of cells counted in two independent treat- mean side scatter (SSC), a measure of cellular granular-
ments). All cells received an equivalent concentration of DMSO. ity or complexity, but not forward side scatter (FSC)
Nocodazole (332 nM) was added at the time of addition of the (data not shown), a measure of cell size. To test whether
suppressors only to ICRF-193 (7 M) pretreated (5 hr) cells, and the increase in SSC was correlated with checkpoint
cells were incubated an additional 18 hr. Suptopin-2 (60 M, 20
status, SSC measurements were analyzed upon pre-g/mL) and to a lesser extent suptopin-1 (32 M, 20 g/mL) in-
treatment of cells with ICRF-193 and a checkpoint sup-creased the mitotic index both in the absence and presence of
pressor plus nocodazole. While FSC did not changeICRF-193. Caffeine (2 mM) and suptopin-3 (51 M, 20 g/mL) only
increased the mitotic index in the presence of ICRF-193. significantly in any of the treatments (data not shown)
(B) Mitotic spreads of cells treated with caffeine and suptopins at and none of the chromatid decatenation checkpoint
the same concentrations as for (A). All cells received an equivalent suppressors altered the SSC levels themselves (Figure
concentration of DMSO. Nocodazole (332 nM) was added at the 6C), the addition of caffeine and, to a lesser extent,
time of addition of the suppressors only to ICRF-193 (7 M) pre-
suptopin-2 and suptopin-3, decreased SSC in cells pre-treated (6 hr) cells and cells incubated for an additional 12 hr. In the
treated with ICRF-193. These data suggest that the in-absence of ICRF-193, suptopin-1 and suptopin-2 caused hypercon-
creased granularity of cells upon treatment with ICRF-densed mitotic chromosomes unlike those of DMSO treated cells,
whereas mitotic cells treated with caffeine and suptopin-3 appeared 193 is due to altered chromatin conformation that occurs
normal. In the presence of ICRF-193, caffeine, suptopin-2, and sup- upon activation of the chromatid decatenation check-
topin-3 showed abnormally elongated chromosomes similar to point.
those described in [22]. Suptopin-1-treated cells showed very few to
no abnormally elongated chromosomes (none visible in experiment
Effect of Suptopinsshown).
on Nucleocytoplasmic Transport
Since overexpression of cyclin B1 or treatment of cells
with leptomycin B was reported to attenuate the deca-
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Figure 6. Dual-Parameter Flow Cytometry of the Effect of Suptopin-2 and Suptopin-3 on the Cell Cycle Distribution and Side Scatter (SSC)
of A549 Cells
(A) DNA content (y axis) and TG-3-FITC signal (x axis). Suppressors were added for a total of 18 hr. All cells received an equivalent concentration
of DMSO. Nocodazole (332 nM) was added at the time of addition of the suppressors only to ICRF-193 (7 M) pretreated (5 hr) cells. Left
panel (DMSO pretreated), suptopin-2 (60 M, 20 g/mL), but not caffeine (2 mM) or suptopin-3 (51 M, 20 g/mL), increased the mitotic index
(area III). Right panel (ICRF-193 pre-treated cells), caffeine (2 mM), suptopin-2 (60 M, 20 g/mL), and suptopin-3 (51 M, 20 g/mL) all
increased the mitotic index (area III).
(B) Quantification of cell cycle distributions in the three areas in (A). Area I, G1 phase (2 N amount of DNA, low TG-3-FITC signal); Area II, G2
phase, 4 N amount of DNA, low TG-3-FITC signal); Area III, M phase, 4 N amount of DNA, high TG-3-FITC signal.
(C) Side scatter (SSC), a measure of cellular granularity/complexity, of cells treated with small molecules as in (A). Caffeine and to a lesser
extent suptopin-3 and suptopin-2 decreased SSC in the presence of ICRF-193 and nocodazole.
tenation checkpoint [18], we tested whether caffeine or 193. In cells pretreated with DMSO (4 hr), none of these
small molecules had a visible effect on the level of ex-suptopin-1 to -3 affected the cellular localization of cyclin
B1 in A549 cells in the presence and absence of ICRF- pression of cyclin B1 (data not shown). Interestingly,
Chemical Genetics of Chromatid Decatenation
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Figure 7. Effect of Suptopin-2 and Lepto-
mycin B on the Intracellular Localization of
Cyclin B1 and Fluorescent Properties of Sup-
topin-2 in A549 Cells
(A) Nuclear (blue, Hoechst 33342) accumula-
tion of cyclin B1 (red; anti-cyclin B1 antibody)
in suptopin-2 (120 M) and leptomycin B
(37 nM) treated cells (4 hr) detected using
fluorescence microscopy. Nuclei are blue
when cyclin B is excluded from the nucleus
and pink when it accumulates in the nucleus.
(B) Percentage of cells (average n  2 treat-
ments, 100 cells counted per treatment)
with cyclin B1 predominantly nuclear de-
tected as in (A). Error bars indicate one stan-
dard deviation from the mean.
(C) Intranuclear localization of intrinsic fluo-
rescence (488 nm excitation) from suptopin-2
(151 M, 20 hr).
suptopin-2 and leptomycin B, but not caffeine, sup- molecules affect the nucleocytoplasmic transport of
other proteins involved in regulating the chromatid de-topin-1, or suptopin-3, caused the nuclear accumulation
of cyclin B1 after a 4 hr treatment (Figure 7A) and in- catenation checkpoint.
creasingly so after a 20 hr treatment (Figure 7B). How-
ever, in cells pretreated with ICRF-193 (18 hr), the in- Relationship of the Chromatid Decatenation,
Chromatin Deacetylation, and Spindlecreased nuclear localization induced by both leptomycin
B and suptopin-2 was not observed, perhaps due to Assembly Checkpoints
One interpretation of the absence of “hit” overlap be-altered accumulation of cyclin B1 in the nucleus upon
prolonged cell cycle arrest (data not shown). In addition, tween the ICRF-193-modifier, TSA-modifier, and anti-
mitotic screens is that the chromatid decatenation,an accumulation of green fluorescent bi- or single-lobed
globular structures within the nucleus of interphase cells chromatin deacetylation, and spindle assembly check-
points use different signaling networks in mammalianwas noted upon suptopin-2 treatment (Figure 7C). We
speculate that the formation of such structures may cells. As a further test for similarities between the signal-
ing networks we determined whether caffeine, an inhibi-sequester nuclear proteins that affect the chromatid de-
catenation checkpoint. The intrinsic fluorescence of tor of ATR that suppresses the decatenation checkpoint,
could suppress the cell cycle effects of trichostatin A.suptopin-2 may prove to be useful in the identification
of its target(s) by biochemical means. Similarly, we tested again whether ITSA1, a suppressor
of trichostatin A, could suppress the cell cycle effectsThe apparent control of cyclin B1 localization by sup-
topin-2 prompted us to test whether any of the suptopins of ICRF-193. These experiments showed that caffeine
has no effect on the cell cycle arrest or on the level ofaffect the nucleocytoplasmic transport of other proteins
regulated by the Crm1-dependent transporter. To do histone H3 acetylation and -tubulin acetylation (data
not shown) induced by trichostatin A and that ITSA1so, we used as a reporter U2OS cells stably transfected
with a human immunodeficiency virus (HIV) Rev-green had no effect on the cell cycle arrest induced by ICRF-
193 (Supplemental Figure S3). Collectively, these resultsfluorescent fusion protein (RevGFP) containing a nuclear
export sequence recognized by Crm1 [46, 47]. Unlike support the notion that the chromatid decatenation
checkpoint functions independently from the chromatinleptomycin B, which caused nuclear accumulation of
the RevGFP reporter [47], suptopin-1 to -3 had little deacetylation checkpoint.
to no effect (Supplemental Figure S2). Although these
assays were performed in a different genetic back- Discussion
ground than the A549 cells and with a reporter protein,
this result suggests that suptopin-2 affects the localiza- The small molecule library used in this study is a com-
mercially available collection of compounds possessingtion of cyclin B1 independent of Crm1-mediated export.
Furthermore, the possibility remains that these small a diverse range of structural properties and chemical
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functionalities. For example, the values (low, high, aver- Of the compounds analyzed here, suptopin-3 was the
most like caffeine in terms of its ability to bypass theage, median) for molecular weights (g/mol) are 157.21,
decatenation checkpoint without having an effect on698.9, 337.73, 322.36, respectively; for calculated solu-
microtubule stability or causing nuclear accumulationbility (cLogP) are 4.69, 9.76, 2.97, 2.99, respectively;
of cyclin B1. Thus, we hypothesize that the cellular inter-for the number of hydrogen bond donors are 0, 10, 1.33,
actions of suptopin-3 are more specifically related to1, respectively; and for the number of hydrogen bond
the chromatid decatentation checkpoint than those ofacceptors are 0, 24, 5.69, 5, respectively (see http://
suptopin-1 or suptopin-2.iccb.med.harvard.edu/screening/compound_libraries/
Unlike the DNA damage G2 checkpoint [1, 2], the in-chembridge_additional.html for more details). However,
duction of the chromatid decatenation checkpoint withwithout rigorous comparison to a collection of reference
ICRF-193 has been reported to be independent of ATMmolecules or some other standard, it is difficult to draw
signaling and to occur in the absence of Chk1 and Chk2precise conclusions about the chemical diversity of the
phosphorylation [18, 20]. However, it is important to notelibrary. Regardless, the dispersion of the four classes of
that although there is evolutionary conservation of thebiological activity across the global map of the chemical
chromatid decatenation checkpoint across at least twospace derived from principal component analysis of the
metazoan kingdoms (plants and animals) [2], its exis-associated molecular descriptors indicates that no par-
tence, at least to date, depends entirely on the use ofticular region of chemical space was favored by any
bis(2,6-dioxopiperazine) derivatives. Thus, if ICRF-193one of the three assays. These results demonstrate that
or the closed-clamp form of TopoII have additional ef-small molecules with very different structures can have
fects on cells, then the induction of the G(2) phase couldthe same phenotypic effect in cell-based assays. This
be due to these other activities [20]. Some support forproperty may derive from the small molecules each tar-
this possibility exists [48–50]; thus, it is possible thatgeting different nodes in the networks regulating the
the suptopins suppress the cell cycle arrest induced byparticular cellular processes involved. Alternatively, as
ICRF-193 through an effect on pathways related to theseexemplified by the small molecules targeting tubulin
other activities of ICRF-193.[41], a diverse range of structures may be capable of
An emerging application of checkpoint suppressorsaffecting a particular protein. In either case, these results
is for the sensitization of tumor cells to damage arisinghighlight the challenging nature of structure-based pre-
as a result of altering DNA metabolism (reviewed in [51]).
diction of biological activity and the derivation of struc-
While cancer treatment often involves combination ther-
ture-activity models using cell-based screening data
apy of multiple chemotherapeutics agents, the notion
only. of sensitizing cells to the effects of a chemotherapeutic
Although the mechanism(s) of action of the suptopins agent by simultaneously eliminating the cellular re-
remain unknown, our findings point to the role of sup- sponse that leads to the perturbations has only recently
topin-2 in regulating nucleocytoplasmic transport. As begun to be explored systematically. One notable ex-
has been observed for the DNA damage-induced G2 ception from a theoretical perspective was the use of
checkpoint, the regulation of the location and activity caffeine by Pardee [52], which can now be rationalized
of Cdk1 and its regulatory subunit cyclin B are key as- due to the inhibition of ATR [24–26]. If eliminating the
pects of the cellular response to altered genomic stabil- chromatid decatenation checkpoint sensitizes tumor
ity [29]. Cyclin B1’s localization is regulated by Crm1, a cells to genomic instability, then one attractive feature of
member of a karyopherin family of nucleocytoplasmic suppressors like the suptopins is that they may operate
transport receptors [27]. Although suptopin-2 does not without affecting DNA damage checkpoints. This might
appear to be a general inhibitor of Crm1-mediated trans- reduce the likelihood that treatment with such a check-
port based upon the Rev-GFP assay (Supplemental Fig- point suppressor leads to mutations in otherwise normal
ure S2), it may specifically interact with a component cells.
unique to cyclin B transport or through a mechanism In summary, the analysis of multidimensional datasets
independent of Crm1. We note that in contrast to the using methods of dimensionality reduction and unsuper-
results described in [18], we did not observe a lepto- vised clustering, such as hierarchical clustering and
mycin B-induced increase in the number of condensed principal component analysis (for example, Figures 3
mitotic chromosomes in the presence of ICRF-193 (data and 4), provide a biologically based means of analyzing
not shown). These differences may be due to the differ- the diversity of small molecules and their effects on
ent genetic backgrounds of the cell lines used, duration biological systems. These global methods of analysis
of treatment, or concentration of leptomycin B. may become increasingly powerful discovery tools in
Since variation exists in the relative affinities of differ- the context of rapidly growing numbers of diverse small
ent small molecule-protein interactions, the stability of molecule modulators and other methods of chemical
different organic molecules, and the abundance of cellu- perturbation, such as ribonucleic acid interference (re-
lar proteins, some small molecules may have multiple viewed in [53]). By combining the results of multiple cell-
and sometimes competing effects in cells at different based assays, phenotypic effects of small molecules
concentrations. Such pleiotropy would explain the abil- can be mapped onto a multidimensional space derived
ity of suptopin-1 and suptopin-2 to increase the mitotic from molecular descriptors analysis yielding a “func-
index in the absence of ICRF-193. Alternatively, since tional map” of chemical space (Figure 3D).
13-hydroxy-15-oxozoapatlin, a recently identified sup-
pressor of the DNA-damage induced G2 checkpoint, also Significance
causes mitotic spindle defects [39], such effects might
be a common property of suppressors of the G2 check- Although there is growing interest in the use of small
molecules as basic research tools, there remains apoints that act different mechanistically from caffeine.
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number of cells in mitosis was assayed using the TG-3 mAb asrelative paucity of such molecules and only limited
described in [40] using a horseradish peroxidase-conjugated anti-approaches to enable their discovery. The chemical
mouse IgM antibody and enhanced chemiluminescent reagents.genetic modifier screen used here to identify small
Data was collected on an Analyst plate reader (LJL Biosystems)
molecule modulators of the human chromatid deca- with an integration time of 0.1 s. For film detection of cytoblots, film
tenation checkpoint illustrates an approach that should was placed on top of the plate for 1–5 min and then developed in
a Kodak M35A X-OMAT processor. After two rounds of retesting,be applicable to the dissection of signaling networks
small molecules that had a TG-3 mAb signal equal to (or greater than)involved in the regulation of other aspects of cell prolif-
the mean plus 1.5 standard deviations of DMSO-treated control cellseration, as well as the mechanism of action, develop-
were considered to be biologically active.ment of resistance to, and metabolism of chemothera-
peutics. Using this approach in the current study, we
Multidimensional Assay and Molecular Descriptor Analysis
provide evidence that the chromatid decatenation Hierarchical clustering of binary (0 no hit, 1 hit) screening results
functions independently from the chromatin deacety- was performed using the unweighted pair-group average method
lation checkpoint. Through consideration of multiple with the Tanimoto distance metric (XLStat-Pro v5.2). A structure
descriptor file containing each small molecule was imported intoscreening datasets, these results provide an example
QSARIS (SciVision, Inc.) for enumeration of a set of 221 graph andof mapping chemical space using a combination of
information theoretic and physiochemical descriptors. 3-D descrip-phenotypic and molecular descriptors. The suptopins
tors were computed using an energy-minimized conformation. De-
provide new molecular tools for investigating the mo- scriptors with zero variance were removed before importing data
lecular mechanism regulating genomic stability in gen- into Microsoft Excel and performing principal component analysis
eral and, more specifically, for illuminating whether (XLStat-Pro v5.2). In the calculation of the global chemical space,
small molecules with missing values (for example due to the pres-inhibiting the chromatid decatenation checkpoint
ence of a counter ion) were removed from the analysis leaving asensitizes tumor cells to certain chemotherapeutic
total of 15,120 small molecules. In the calculation of the local chemi-agents.
cal space of only the ICRF-193 suppressors, missing values for two
small molecules (51 N16 and 37 A17) were replaced by the descriptor
Experimental Procedures means. Visualization of 3-dimensional PCA models was performed
by importing the coordinates of compounds after PCA into Spotfire
Materials Descision Site software (v7.0).
Trichostatin A, nocodazole, and ribonuclease A were purchased
from Sigma. Propidium iodide, Hoechst 33342, Hoechst 33258, and
Fluorescence MicroscopyTexas methyl red-conjugated anti-mouse IgG antibody were pur-
For mitotic spreads, A549 cells (75% confluent) in 10 cm disheschased from Molecular Probes. ITSA1 (5253409), suptopin-1 (5146479),
treated as indicated were trypsinized cells and pelleted (2 min) atsuptopin-2 (5118575), and suptopin-3 (5244640) were purchased
1000 rpm on a Beckman tabletop centrifuge. The supernatant wasfrom ChemBridge. ICRF-193 was a gift from Dr. James Wang (Har-
aspirated and 1 ml of 75 mM potassium chloride added to swellvard University). Fluorescein isothiocyanate-conjugated anti-mouse
cells (10 min). Cells were pelleted, supernatant aspirated, and cellsIgM was purchased from Calbiochem. Enhanced chemiluminescent
resuspendend in 0.5 ml Carnoy’s fixative (1:3 acetic acid:methanol,reagents were purchased from Amersham Pharmacia. Anti-cyclin
20C, 10 min). Cells were pelleted and all but 50–100 l of theB1 antibody was purchased from Santa Cruz. Anti-TG-3 mAb was
supernatant aspirated. After resuspending, 15 l per sample wasa gift from Dr. Peter Davies (Albert Einstein College of Medicine).
spotted from a height of 10 cm onto glass slides and allowed to dry384-well pin arrays were purchased from Genetix. X-OMAT AR film
before staining (10 min) with Hoechst (1 g/mL in Tris-bufferedwas purchased from Kodak Corporation. FuGENE 6 transfection
saline [TBS] and mounting. For detection of microtubules and actinregents were purchased from Boehinger Mannheim. All cell culture
(data not shown), A549 cells were seeded onto glass coverslips atreagents were purchased from Gibco, BRL.
80%–90% confluency, and small molecules added after diluting
in cellular medium. Cells were fixed in glutaraldehyde (0.2%) in a
Cell Culture permeabilization buffer (50 mM K-Pipes [pH 6.8], 5 mM EGTA,
A549 cells (ATCC, human lung carcinoma) were maintained at 37C, 0.5 mM MgCl2, and 0.1% Triton X-100) for 15 min, quenched (10
5% CO2 in Dulbecco’s modified Eagle medium (DMEM) supple- min) in sodium borohydride (10 mg/mL) in TBS/0.1% Triton X-100
mented with 10% fetal bovine serum (FBS), 100 units/mL penicillin (TBS-T), and stained with fluorescein isothiocyanate-conjugated
G sodium, 100 g/ml streptomycin sulfate (1% P/S), and 2 mM (FITC)-conjugated anti--tubulin antibody (DM1; 1:500), TMR-con-
L-glutamine (1% L-Gln) (DMEM). U2OS (human osteosarcoma)- jugated phalloidin (2 g/mL), and Hoechst 33342 (1 g/mL) diluted
RevGFP cells were maintained as for A549 cells and grown in DMEM in antibody dilution buffer (ADB, TBS-T/2% bovine serum albumin/
containing 10% Fetal Clone (DMEMC). These cells were established 0.1% sodium azide). For detection of cyclin B1, cells were fixed in
by transfecting U2OS cells with pRev(1.4)-GFPPKI NES (gift from methanol (100%, 20C, 5–20 min), washed twice in ADB and
Dr. Beric Henderson [47]) with FuGENE 6 according to the manufac- blocked overnight in ADB. Cells were stained with an anti-cyclin
turer’s directions. Stable clones were selected in complete media B1 antibody (1:50) and Hoechst 33342 (1 g/ml) dye diluted ADB
containing 400 g/mL G418. followed by a secondary TMR-conjugated anti-mouse IgG antibody
(1:500). For detection of suptopin-2 fluorescence, A549 cells were
illuminated between 364 and 514 nm using a longpass filter, with aTG-3 Cytoblot Assay
A549 cells were seeded in 45 l DMEM (4000 cells/well) in white peak emission occurring at an excitation wavelength of 488 nm, and
no emission occurring at or above 543 nm. Images of mitotic spreads384-well plates (Nalge Nunc, tissue culture treated) using a liquid
dispenser (Multidrop 384, Labsystems) and allowed to attach over- were collected on a Leitz Laborlux 2 microscope with a 40	PHACO2
objective. Images of microtubule/actin cytoskeleton (data notnight at 37C with 5% CO2. ICRF-193 (5 l) ([final]  7 M) was
added to each well, and incubation continued for 5 hr. Since ICRF- shown) and cyclin B1 localization were collected on a Zeiss LSM510
confocal scanning laser microscope using a 63	 objective using193 is dominant to the addition of nocodazole, cells are prevented
from entering mitosis and the basal signal from the mitosis-specific the accompanying software. For the RevGFP export assay, U2OS-
RevGFP cells were seeded onto clear-bottom, black 384-well platesphosphorylation-sensitive epitope recognized by the TG-3 mAb was
low [36]. Library compounds (9600 molecules, Diverse E set, Chem- (Costar) at a density of 4500 cells/well in 50 l DMEMC. Cells were
allowed to attach and grow overnight before compound treatment.Bridge) dissolved in DMSO (5 mg/ml) were then pin transferred
(50–200 nL to each well, [final]  20 M/well) using disposable Compounds were diluted 1:125 in DMEM and serially diluted 1:2 in
a separate 384-well plate. Media was aspirated from cells before384-well pin arrays and nocodazole (332 nM final concentration), a
microtubule destabilizer, added to arrest cells that have bypassed the diluted compounds were transferred onto them. Cells were incu-
bated with compound for 1 hr before fixation with 3.7% formalde-the checkpoint and entered mitosis. Following 16 hr incubation, the
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hyde and nuclei staining with Hoechst 33258 at 2 g/mL. RevGFP 10. Andoh, T., and Ishida, R. (1998). Catalytic inhibitors of DNA
topoisomerase II. Biochim. Biophys. Acta 1400, 155–171.localization was then imaged with an inverted fluorescence micro-
scope containing a 20	 ELWD objective (Nikon) and Metamorph 11. Abraham, R.T. (2001). Cell cycle checkpoint signaling through
the ATM and ATR kinases. Genes Dev. 15, 2177–2196.software (Universal Imaging).
12. Shiloh, Y. (2001). ATM and ATR: networking cellular responses
to DNA damage. Curr. Opin. Genet. Dev. 11, 71–77.Flow Cytometry
13. Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S.J., and Qin,A549 cells (75% confluent) in 10 cm dishes were pretreated with
J. (2000). BASC, a super complex of BRCA1-associated proteinsDMSO (0.1% v/v) or ICRF-193 (7 M) for 6 hr. Small molecules
involved in the recognition and repair of aberrant DNA struc-were added at the indicated concentrations for an additional 18 hr.
tures. Genes Dev. 14, 927–939.Samples were rinsed in PBS, trypsinized, fixed (30 min, 3.7% formal-
14. Futaki, M., and Liu, J.M. (2001). Chromosomal breakage syn-dehyde in TBS, room temperature; 5 min 100% methanol [20C],
dromes and the BRCA1 genome surveillance complex. Trendswashed in TBS/1% bovine serum albumin (TBS-B), and stored over-
Mol. Med. 7, 560–565.night in TBS-B (4C). To determine the number of cells in M phase
15. Tanabe, K., Ikegami, Y., Ishida, R., and Andoh, T. (1991). Inhibi-[45], samples were washed and incubated (4C; shaking) in ADB
tion of topoisomerase II by antitumor agents bis(2,6-dioxopiper-with TG-3 mAb (1:60 v/v from ascites fluid) and FITC-conjugated
azine) derivatives. Cancer Res. 51, 4903–4908.anti-mouse IgM (1:200 v/v, for 9 hr). Cells were washed three times
16. Downes, C.S., Clarke, D.J., Mullinger, A.M., Gimenez-Abian,(2 mL) of TBS, resuspended in ribonuclease A (100 L, 100 g/
J.F., Creighton, A.M., and Johnson, R.T. (1994). A topoisomer-mL), and incubated 10 min (37C). To measure the DNA content,
ase II-dependent G2 cycle checkpoint in mammalian cells. Na-propidium iodide ([PI] 400 L, 50 g/mL) was added and incubated
ture 372, 467–470.1 hr at room temperature. Samples were analyzed using a FACScanII
17. Kaufmann, W.K., and Kies, P.E. (1998). DNA signals for G2flow cytometer (Becton-Dickinson) at the Dana Farber Cancer Insti-
checkpoint response in diploid human fibroblasts. Mutat. Res.tute, exciting at 488 nm and measuring PI fluorescence through
400, 153–167.a 600 nm band-pass filter. Cell cycle distributions and apoptosis
18. Deming, P.B., Cistulli, C.A., Zhao, H., Graves, P.R., Piwnica-analysis were modeled using ModFit LT (v2.0) software. Side scatter
Worms, H., Paules, R.S., Downes, C.S., and Kaufmann, W.K.(SSC) measurements, which are affected by the granularity or com-
(2001). The human decatenation checkpoint. Proc. Natl. Acad.
plexity of cellular contents upon laser excitation, were collected
Sci. USA 98, 12044–12049.
while sorting cells.
19. Munoz, P., Baus, F., and Piette, J. (2001). Ku antigen is required
to relieve G2 arrest caused by inhibition of DNA topoisomerase
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